−0.3067SEK
−22.71 MSEK
6.97 MSEK
About S2MEDICAL AB SER. B
Sector
Industry
CEO
Petter Sivlér
Website
Headquarters
Linköping
Founded
2013
ISIN
SE0011725084
FIGI
BBG00MMCBXY8
S2Medical AB engages in research and development in biotechnology. The firm is also involved in the development and sale of wound healing products focusing on burns and chronic wounds. It offers skin substitutes, odor remover, collagen, and bandages products. The company was founded by Petter Sivlér and Mårten Skog on June 13, 2013 and is headquartered in Linköping, Sweden.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of S2M is 0.0533 SEK — it has decreased by 9.04% in the past 24 hours. Watch S2MEDICAL AB SER. B stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange S2MEDICAL AB SER. B stocks are traded under the ticker S2M.
S2M stock has risen by 8.78% compared to the previous week, the month change is a 38.17% fall, over the last year S2MEDICAL AB SER. B has showed a 82.81% decrease.
S2M stock is 36.44% volatile and has beta coefficient of 1.24. Track S2MEDICAL AB SER. B stock price on the chart and check out the list of the most volatile stocks — is S2MEDICAL AB SER. B there?
Today S2MEDICAL AB SER. B has the market capitalization of 14.52 M, it has increased by 6.94% over the last week.
Yes, you can track S2MEDICAL AB SER. B financials in yearly and quarterly reports right on TradingView.
S2M net income for the last quarter is 804.00 K SEK, while the quarter before that showed −3.82 M SEK of net income which accounts for 121.03% change. Track more S2MEDICAL AB SER. B financial stats to get the full picture.
No, S2M doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. S2MEDICAL AB SER. B EBITDA is −8.52 M SEK, and current EBITDA margin is −211.01%. See more stats in S2MEDICAL AB SER. B financial statements.
Like other stocks, S2M shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade S2MEDICAL AB SER. B stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So S2MEDICAL AB SER. B technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating S2MEDICAL AB SER. B stock shows the sell signal. See more of S2MEDICAL AB SER. B technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.